Mario Lorenz
Impact in
- Aging top 1%
- Genetics, Aging, and Longevity in Model Organisms
- Biochemistry top 0.5%
- Phytochemicals and Antioxidant Activities
- Antioxidant Activity and Oxidative Stress
Papers in
-
- Ubiquitin and proteasome pathways 4
-
- Tea Polyphenols and Effects 19
- Co-authors
- Verena Stangl (34 shared papers)Gert Baumann (19 shared papers)Karl Stangl (16 shared papers)Karl Stangl (10 shared papers)Thomas von Zglinicki (5 shared papers)Gabriele Saretzki (5 shared papers)Violeta Serra (3 shared papers)Antje Ludwig (7 shared papers)
- Journals
- Atherosclerosis (3 papers)Journal of Clinical Oncology (3 papers)The FASEB Journal (2 papers)Free Radical Biology and Medicine (2 papers)PLoS ONE (2 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Mario Lorenz
64 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 136
- Aging 205
- Biochemistry 669
- Pathology and Forensic Medicine 911
- Biological Psychiatry 98
- Physiology 811
Countries citing papers authored by Mario Lorenz
This map shows the geographic impact of Mario Lorenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Lorenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Lorenz more than expected).
Fields of papers citing papers by Mario Lorenz
This network shows the impact of papers produced by Mario Lorenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Lorenz. The network helps show where Mario Lorenz may publish in the future.
Co-authors
The 25 scholars most cited alongside Mario Lorenz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 277 | |
| 2 | 2000 | 247 | |
| 3 | 2003 | 205 | |
| 4 | 2006 | 188 | |
| 5 | 2006 | 181 | |
| 6 | 2002 | 172 | |
| 7 | 2004 | 168 | |
| 8 | 2006 | 126 | |
| 9 | Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas. | 2002 | 117 |
| 10 | 2011 | 107 | |
| 11 | 2004 | 105 | |
| 12 | Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase. | 2001 | 97 |
| 13 | 2007 | 92 | |
| 14 | 2008 | 90 | |
| 15 | 2005 | 89 | |
| 16 | 2006 | 77 | |
| 17 | 2002 | 77 | |
| 18 | 2009 | 69 | |
| 19 | 2015 | 66 | |
| 20 | 2013 | 65 |
About Mario Lorenz
Mario Lorenz is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Physiology, Biochemistry and Cardiology and Cardiovascular Medicine, having authored 69 papers that have together received 3.6k indexed citations. Recurring topics across this work include Tea Polyphenols and Effects (19 papers), Phytochemicals and Antioxidant Activities (10 papers), Antioxidant Activity and Oxidative Stress (7 papers), Telomeres, Telomerase, and Senescence (6 papers), Nitric Oxide and Endothelin Effects (5 papers), Ginkgo biloba and Cashew Applications (5 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Ubiquitin and proteasome pathways (4 papers). The work is most often cited by research in Aging (205 citations), Biochemistry (669 citations), Pathology and Forensic Medicine (911 citations), Biological Psychiatry (98 citations) and Physiology (811 citations). Mario Lorenz has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Verena Stangl, Gert Baumann, Karl Stangl, Karl Stangl, Thomas von Zglinicki, Gabriele Saretzki, Violeta Serra, Antje Ludwig, Henryk Dreger and M. Aaron Benjaminson. Their work appears in journals such as Atherosclerosis, Journal of Clinical Oncology, The FASEB Journal, Free Radical Biology and Medicine and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.